PMC:3586680 / 5424-5554 JSONTXT

{"project":"test3","denotations":[{"id":"T864","span":{"begin":109,"end":114},"obj":"Protein"},{"id":"T863","span":{"begin":95,"end":107},"obj":"Protein"},{"id":"T830","span":{"begin":109,"end":114},"obj":"Protein"},{"id":"T829","span":{"begin":95,"end":107},"obj":"Protein"}],"relations":[{"id":"R461","pred":"equivalentTo","subj":"T864","obj":"T863"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"testone","denotations":[{"id":"T793","span":{"begin":95,"end":107},"obj":"Protein"},{"id":"T794","span":{"begin":109,"end":114},"obj":"Protein"}],"relations":[{"id":"R451","pred":"equivalentTo","subj":"T794","obj":"T793"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T3324","span":{"begin":117,"end":130},"obj":"NN"},{"id":"T3323","span":{"begin":115,"end":116},"obj":","},{"id":"T3322","span":{"begin":114,"end":115},"obj":"-RRB-"},{"id":"T3321","span":{"begin":109,"end":114},"obj":"NNP"},{"id":"T3320","span":{"begin":108,"end":109},"obj":"-LRB-"},{"id":"T3319","span":{"begin":95,"end":107},"obj":"NNP"},{"id":"T3318","span":{"begin":93,"end":94},"obj":"."},{"id":"T3317","span":{"begin":92,"end":93},"obj":"-RRB-"},{"id":"T3316","span":{"begin":88,"end":92},"obj":"CD"},{"id":"T3315","span":{"begin":86,"end":87},"obj":","},{"id":"T3314","span":{"begin":83,"end":86},"obj":"FW"},{"id":"T3313","span":{"begin":80,"end":82},"obj":"FW"},{"id":"T3312","span":{"begin":71,"end":79},"obj":"NNP"},{"id":"T3311","span":{"begin":70,"end":71},"obj":"-LRB-"},{"id":"T3310","span":{"begin":66,"end":69},"obj":"NNP"},{"id":"T3309","span":{"begin":56,"end":65},"obj":"JJ"},{"id":"T3308","span":{"begin":52,"end":55},"obj":"CC"},{"id":"T3307","span":{"begin":42,"end":51},"obj":"JJ"},{"id":"T3306","span":{"begin":37,"end":41},"obj":"IN"},{"id":"T3305","span":{"begin":28,"end":36},"obj":"NNS"},{"id":"T3304","span":{"begin":25,"end":27},"obj":"IN"},{"id":"T3303","span":{"begin":14,"end":24},"obj":"NN"},{"id":"T3302","span":{"begin":10,"end":13},"obj":"NNP"},{"id":"T3301","span":{"begin":2,"end":9},"obj":"VB"}],"relations":[{"id":"R2359","pred":"ROOT","subj":"T3301","obj":"T3301"},{"id":"R2360","pred":"compound","subj":"T3302","obj":"T3303"},{"id":"R2361","pred":"dobj","subj":"T3303","obj":"T3301"},{"id":"R2362","pred":"prep","subj":"T3304","obj":"T3301"},{"id":"R2363","pred":"pobj","subj":"T3305","obj":"T3304"},{"id":"R2364","pred":"prep","subj":"T3306","obj":"T3305"},{"id":"R2366","pred":"amod","subj":"T3307","obj":"T3310"},{"id":"R2367","pred":"cc","subj":"T3308","obj":"T3307"},{"id":"R2368","pred":"conj","subj":"T3309","obj":"T3307"},{"id":"R2370","pred":"pobj","subj":"T3310","obj":"T3306"},{"id":"R2371","pred":"punct","subj":"T3311","obj":"T3310"},{"id":"R2372","pred":"nmod","subj":"T3312","obj":"T3314"},{"id":"R2374","pred":"nmod","subj":"T3313","obj":"T3314"},{"id":"R2375","pred":"dep","subj":"T3314","obj":"T3301"},{"id":"R2378","pred":"punct","subj":"T3315","obj":"T3314"},{"id":"R2380","pred":"npadvmod","subj":"T3316","obj":"T3314"},{"id":"R2381","pred":"punct","subj":"T3317","obj":"T3314"},{"id":"R2382","pred":"punct","subj":"T3318","obj":"T3301"},{"id":"R2385","pred":"punct","subj":"T3320","obj":"T3321"},{"id":"R2386","pred":"appos","subj":"T3321","obj":"T3319"},{"id":"R2387","pred":"punct","subj":"T3322","obj":"T3321"},{"id":"R2389","pred":"punct","subj":"T3323","obj":"T3319"},{"id":"R2390","pred":"appos","subj":"T3324","obj":"T3319"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T2478","span":{"begin":95,"end":130},"obj":"Entity"},{"id":"T2402","span":{"begin":10,"end":13},"obj":"Entity"},{"id":"T2367","span":{"begin":95,"end":116},"obj":"Protein"},{"id":"T2361","span":{"begin":109,"end":114},"obj":"Protein"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"DLUT931","denotations":[{"id":"T2178","span":{"begin":109,"end":114},"obj":"Protein"},{"id":"T2177","span":{"begin":95,"end":107},"obj":"Protein"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"BioNLP16_Messiy","denotations":[{"id":"T2254","span":{"begin":109,"end":114},"obj":"Protein"},{"id":"T2253","span":{"begin":95,"end":107},"obj":"Protein"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"BioNLP16_DUT","denotations":[{"id":"T2120","span":{"begin":109,"end":114},"obj":"Protein"},{"id":"T2119","span":{"begin":95,"end":107},"obj":"Protein"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T1961","span":{"begin":109,"end":114},"obj":"Protein"},{"id":"T1960","span":{"begin":95,"end":107},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"pmc-enju-pas","denotations":[{"id":"T1700","span":{"begin":117,"end":130},"obj":"NN"},{"id":"T1699","span":{"begin":115,"end":116},"obj":"-COMMA-"},{"id":"T1698","span":{"begin":114,"end":115},"obj":"-RRB-"},{"id":"T1697","span":{"begin":109,"end":114},"obj":"NN"},{"id":"T1696","span":{"begin":108,"end":109},"obj":"-LRB-"},{"id":"T1695","span":{"begin":95,"end":107},"obj":"NN"},{"id":"T1694","span":{"begin":92,"end":93},"obj":"-RRB-"},{"id":"T1693","span":{"begin":88,"end":92},"obj":"CD"},{"id":"T1692","span":{"begin":86,"end":87},"obj":"-COMMA-"},{"id":"T1691","span":{"begin":83,"end":86},"obj":"FW"},{"id":"T1690","span":{"begin":80,"end":82},"obj":"FW"},{"id":"T1689","span":{"begin":71,"end":79},"obj":"NNP"},{"id":"T1688","span":{"begin":70,"end":71},"obj":"-LRB-"},{"id":"T1687","span":{"begin":66,"end":69},"obj":"NN"},{"id":"T1686","span":{"begin":56,"end":65},"obj":"JJ"},{"id":"T1685","span":{"begin":52,"end":55},"obj":"CC"},{"id":"T1684","span":{"begin":42,"end":51},"obj":"JJ"},{"id":"T1683","span":{"begin":37,"end":41},"obj":"IN"},{"id":"T1682","span":{"begin":28,"end":36},"obj":"NN"},{"id":"T1681","span":{"begin":25,"end":27},"obj":"IN"},{"id":"T1680","span":{"begin":14,"end":24},"obj":"NN"},{"id":"T1679","span":{"begin":10,"end":13},"obj":"NN"},{"id":"T1678","span":{"begin":2,"end":9},"obj":"VB"}],"relations":[{"id":"R1228","pred":"arg2Of","subj":"T1680","obj":"T1678"},{"id":"R1229","pred":"arg1Of","subj":"T1680","obj":"T1679"},{"id":"R1230","pred":"arg1Of","subj":"T1680","obj":"T1681"},{"id":"R1231","pred":"arg1Of","subj":"T1680","obj":"T1683"},{"id":"R1232","pred":"arg2Of","subj":"T1682","obj":"T1681"},{"id":"R1233","pred":"arg1Of","subj":"T1684","obj":"T1685"},{"id":"R1234","pred":"arg2Of","subj":"T1686","obj":"T1685"},{"id":"R1235","pred":"arg2Of","subj":"T1687","obj":"T1683"},{"id":"R1236","pred":"arg1Of","subj":"T1687","obj":"T1684"},{"id":"R1237","pred":"arg1Of","subj":"T1687","obj":"T1686"},{"id":"R1238","pred":"arg1Of","subj":"T1687","obj":"T1688"},{"id":"R1239","pred":"arg2Of","subj":"T1689","obj":"T1688"},{"id":"R1240","pred":"arg1Of","subj":"T1689","obj":"T1690"},{"id":"R1241","pred":"arg1Of","subj":"T1689","obj":"T1691"},{"id":"R1242","pred":"arg1Of","subj":"T1689","obj":"T1692"},{"id":"R1243","pred":"arg2Of","subj":"T1693","obj":"T1692"},{"id":"R1244","pred":"arg3Of","subj":"T1694","obj":"T1688"},{"id":"R1245","pred":"arg1Of","subj":"T1695","obj":"T1696"},{"id":"R1246","pred":"arg1Of","subj":"T1695","obj":"T1699"},{"id":"R1247","pred":"arg2Of","subj":"T1697","obj":"T1696"},{"id":"R1248","pred":"arg3Of","subj":"T1698","obj":"T1696"},{"id":"R1250","pred":"arg2Of","subj":"T1700","obj":"T1699"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"2_test","denotations":[{"id":"23459853-21406402-38778516","span":{"begin":88,"end":92},"obj":"21406402"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}

{"project":"simple1","denotations":[{"id":"T2068","span":{"begin":109,"end":114},"obj":"Protein"},{"id":"T2067","span":{"begin":95,"end":107},"obj":"Protein"}],"text":"y reverse TMZ resistance in patients with resistant and recurrent GBM (Goellner et al., 2011). Interferon-β (IFN-β), levetiracetam"}